Obstructive uropathy is a disorder of the urinary tract that occurs due to obstructed urinary flow and can be either structural or functional. The back-up of urine into the unilateral or bilateral kidneys, depending on the location of the obstruction, causes hydronephrosis. The obstruction can present as a motley of symptoms but will typically involve a combination of difficultly initiating micturition, acute urinary retention, or lower abdominal discomfort and distention. The condition can be acute or chronic. It can occur across all age groups and demographics. This article will provide a detailed review of obstructive uropathy.
There are a significant number of potential causes of obstructive uropathy, and these vary widely. However, the most frequently diagnosed cause is benign prostatic hypertrophy or hyperplasia. Although not particularly common, other potential causes include constipation, urethral strictures, phimosis or paraphimosis, prostatic adenocarcinoma, retroperitoneal adenopathy, colonic endometriosis, ureterocele, urolithiasis, and neuropathic bladder dysfunction, parasitic obstructions, bladder endometriosis, and urate nephrolithiasis. The history and physical examinations are key in the diagnosis of the underlying cause. Obstructive uropathy can also present in the neonatal period, prompting evaluation for genitourinary tract dilatation and vesicoureteral reflux and highlighting the importance of intrauterine fetal anatomy ultrasounds.
Urinary obstruction affects all age groups, but the majority of cases present in the bimodal distribution in infants and the elderly. Congenital genitourinary tract abnormalities (e.g., posterior urethral valves) present in childhood as urinary obstruction, producing an estimate of approximately 4% of the total cases. The largest group is made up of people over 60 and more frequently males due to the anatomic presence of prostate (benign prostatic hyperplasia and cancers). Symptoms of urinary retention occur in up to 1% to 2% of men with BPH per year. Obstructive uropathy is significantly less common in females.
When there is a restriction to the normal flow of urine through the urinary tract, there will be a back pressure of urine into the collecting system of the kidneys. In time, this may produce dilatation within the tract, and as the kidneys filtration system becomes affected, it becomes the primary reason for the development of obstructive nephropathy. The mechanism of nephropathy, in this case, involves many factors, including local ischemia due to distention and increased intratubular pressures. In a partial obstruction, angiotensin and AT1-receptor appear to be upregulated, increasing ureteral peristalsis to help relieve the obstruction.
While peristaltic function may be of benefit in a partial obstruction, it is likely to cause increased distention and intraluminal pressures when the obstruction is complete. Rat models have also demonstrated influence from the renin-angiotensin-aldosterone axis, and TGF-beta1 expression was markedly increased in hydronephrotic kidneys, which may occur in humans as well, but further studies are needed. These factors may lead to irreversible damage to the kidney, but it is difficult to predict the time and rate at which this will occur. This highlights the importance of early identification and treatment of the underlying obstruction.
The severity of symptoms and likely even the number of symptoms present are influenced by the degree, location, and time from the onset of the obstruction. The presence of pain is common in urinary tract obstructions. Patients may present with abdominal and/or flank pain. The location, quality, severity, and modifying factors of the discomfort may help to aid in determining the location and underlying cause. For example, dull flank pain with sharp radiation into the lower quadrant or groin may suggest ureterolithiasis as the underlying cause of obstruction.
Nocturia, dysuria, urinary urgency or frequency, and decreased force of urinary stream should suggest benign prostatic hypertrophy/hyperplasia or prostatic adenocarcinoma. Fever should increase your concern for concomitant urinary tract infection and, possibly, septicemia. Prostatic malignancy should be considered in the presence of recent unintentional weight loss, night sweats, and hematuria with a nodular prostate on examination. Radiation and other treatments for prior malignancies can increase scarring in the GU tract and produce obstruction. Gastrointestinal symptoms of constipation, nausea, vomiting, and diarrhea may aid in diagnosing fecal impaction, bowel obstruction, or a colonic mass as contributing factors to the urinary tract obstructions. Recent surgeries (e.g., appendectomy, hysterectomy) can suggest ureteral injury. As evidenced above, providers must perform a complete history and a thorough review of systems.
A complete examination should be performed, focusing on the abdomen and genitalia. The presence of a distended bladder should direct the clinician to the possibility of urinary retention. A digital rectal examination may reveal prostatic enlargement or fecal impaction. An assessment of strength, sensation, reflexes, and muscle tone can be informative. A thorough history and physical examination will often point towards the underlying etiology.
A basic metabolic panel should be performed in most patients with evidence of obstructive uropathy, with a specific focus on the patient's renal function. Urinalysis should be performed to rule out urinary tract infection. Urine protein-to-creatinine ratio and urine electrolytes may be beneficial for guiding further care. A bedside ultrasound should be performed to quickly assess the bladder volume and the severity of hydronephrosis. Ultrasound is the most readily available and least invasive test. A comprehensive ultrasound can also be performed for further assessment. The next radiographic test to be considered for most providers would be a CT of the abdomen and pelvis, especially if there is a concern for intra-abdominal pathologies, such as tumors. Additional testing to be considered in specific circumstances would be intravenous pyelogram, voiding cystourethrogram, and renal nuclear scans. MRI can also be considered.
Electrolyte abnormalities should be corrected, as indicated. If renal function is significantly worse from baseline, or there are significant electrolyte abnormalities, hospital admission and urgent nephrology consultation may be warranted. Urinalysis is likely to be performed to rule out infection, and antibiotics should be prescribed as indicated. Urine samples are often also sent for culture.
The treatment of obstructive uropathy is based around promptly addressing the obstructive process. Bladder volume measurements can help to guide further therapies from this point. A Foley catheter is likely to be attempted, particularly if the obstruction is due to the most frequent etiology, benign prostatic hypertrophy, or hyperplasia. The initial attempt usually occurs with a 16- or 18-Fr Foley. The presence of obstruction may prevent the initial success of urethral catheterization and may require higher-level interventions. The most typical next step would be a trial of urethral catheterization using a Coudé tip Foley, but more significant interventions may be required and are addressed in other articles.
While unlikely, suprapubic catheterization or cystostomy may be required for cases when urethral catheterization is not feasible. The duration of time the Foley should be in place is based on a combination of the initial bladder volume and post-catheterization residual. This decision often occurs in conjunction with a urologist. Outpatient follow-up with urology should be arranged as they will play a significant role in determining the need for and guiding long-term therapies. The Foley catheter will be removed at the discretion of the urologist at follow-up. Infrequently, individuals may fail the trial without a catheter, resulting in the replacement of the catheter. At this point, additional interventions may be indicated, including ureteral stents, drains, or placement of nephrostomy tubes. There may be a potential benefit of more invasive procedures for the management of obstructions that fail more conservative management, and these include prostate artery embolization.
There are certain cases where medication therapies may be pursued. Medications that inhibit alpha-1-adrenergic receptors (e.g., tamsulosin, terazosin), which result in relaxation of the smooth muscle within the bladder neck and prostate, have been indicated to improve symptoms of urinary obstructive secondary to BPH. Tamsulosin demonstrated having a positive effect for moderate to severe obstructive symptoms due to benign prostatic hypertrophy. While orthostasis is a commonly cited concern with the use of this medication, several studies have suggested the absence of any significant side effects. Bicalutamide and leuprolide, which act via antiandrogen and luteinizing hormone agonism, respectively, may help to relieve obstruction by shrinking the prostate.
Finasteride and dutasteride are each FDA-approved for the treatment of BPH. These medications act by inhibiting the 5-alpha-reductase enzyme, blocking the conversion of testosterone to dihydrotestosterone, and reducing prostate size. Several of these medical therapies may be combined and are likely to produce a synergistic effect.
Management of nephropathy due to obstruction also begins with relieving the urinary tract obstruction, but is an entire topic in itself and will not be discussed further here.
Differential diagnoses are broad and dependent on location, timing, and risk factors. A detailed history and thorough physical examination allow for inclusion, or exclusion, of differentials. The presence of urinary retention may be secondary to an obstruction, infection, medication side effect, neurogenic, secondary to spinal cord impingement, detrusor muscle dysfunction, and may also be acute or chronic in nature.
Fever or other constitutional symptoms can point towards infectious etiologies, such as pyelonephritis or spinal epidural abscess. Unilateral flank pain and known renal stone disease could indicate obstruction from ureterolithiasis. Prior urologic instrumentation procedures should lead the provider to consider urethral strictures or blood clots as a cause of obstruction. The presence of neurologic deficits should prompt evaluation for stroke or spinal cord diseases.
History of intravenous drug use can suggest epidural abscess or discitis. The presence of malignancy raises suspicion for spinal cord or vertebral metastases. Aortic aneurysm or dissection should be considered as a cause of flank pain in a patient with a history of hypertension and smoking. Constipation or the presence of a fecal impaction could produce obstruction in the urinary tract. Medication changes or recent anesthetic events may lead to symptoms of retention. As with all patient presentations, history and physical examination will guide your differential diagnoses and diagnostic workups.
Prognosis depends on the underlying etiology of the obstruction. An acute urologic obstruction is more likely to be reversible and less likely to produce damage to the kidney filtration system or other functions. However, chronic obstruction produces worse long-term effects on renal function. The development of chronic renal problems is less likely if only one of the kidneys is affected by the initial obstructive process. Although uncommon after the resolution of acute obstruction, if renal dysfunction persists or worsens, long term outlook could include the need for hemodialysis or renal transplant. The overall prognosis worsens if concomitant UTIs remain untreated.
Complications are often the result of the underlying cause, and management of these vary on a case-by-case basis. However, as mentioned above, an obstruction can lead to permanent damage and possibly failure of the kidneys. Again, while this is less likely to occur during an acute obstruction, it remains possible, and the likelihood increases if the obstruction is chronic. It is especially important to recognize signs of obstruction in fetuses and neonates, as it is the leading cause of renal failure and would cause significant long-term morbidity and mortality for the child. For children with chronic renal failure, obstructive uropathy was felt to be accountable for 16.5% of all pediatric renal transplants.
The identification of these issues in utero can improve the overall outlook for these children, highlighting the importance of the anatomic fetal ultrasound. Obstructive uropathy has been suggested to increase the likelihood of urinary tract infections, but UTI may also be the first sign of obstruction.
Microscopic hematuria is common following urethral catheterization, but more significant bleeding can occur, and these would require intervention (possibly continuous bladder irrigation through a 3-way Foley). Transient hypotension and bradycardia may occur after placement of the Foley but generally resolves with observation alone.
Previously, it was thought that the bladder should be drained more gradually due to hypotension, but more recent studies have demonstrated no significant difference in outcomes between rapid and gradual drainage. Postobstructive diuresis, which is addressed further in a separate article, may occur, and these patients may benefit from hospital observation for close monitoring of vital signs and electrolytes.
A consultation with urology will be at the foundation of most newly diagnosed obstructive uropathies, as GU tract obstruction is a primary urologic issue. Additional consultations will vary based on the underlying etiology of the obstruction but may range from urology alone to a multidisciplinary approach, such as with a newly diagnosed mass as the source of obstruction.
The patient with obstructive uropathy should be educated on catheter care, including how to properly secure the catheter, and on monitoring urine output. Advise the patient regarding potential reasons to seek immediate care (e.g., fever, blocked Foley, gross hematuria, severe pain). They should be counseled on the importance of adherence to recommended follow up plans, both for management of underlying conditions and to prevent recurrent obstructions. If medications are being prescribed, it is important to inform the patient of potential side effects.
Obstructive uropathy can affect an individual in any age group and from an extremely wide variety of demographics. The management of the condition producing the obstruction does not stop at the first visit to a clinic, or in the emergency department, and it is likely this may require a multidisciplinary approach. The first example includes an ovarian mass, which may require urology, gynecology, oncology (or gynecological oncology), to list a few. A second example could be for a gastrointestinal malignancy producing urologic obstruction, which may require urology, gastroenterology, oncology, and general surgery, among others. A diagnosis of posterior urethral valves producing obstruction in an infant male would create a need for an entirely different team of specialists.
If the underlying etiology of the obstruction is likely to cause issues with a patient's mental health, as with a newly diagnosed cancer, we should help to arrange psychological therapies. The point being that coordination with multiple specialists takes time and can be frustrating, but our focus should remain on the patient and helping them to cope with their new diagnosis. (Level IV)
|||Yap E,Salifu M,Ahmad T,Sanusi A,Joseph A,Mallappallil M, Atypical Causes of Urinary Tract Obstruction. Case reports in nephrology. 2019; [PubMed PMID: 30937201]|
|||Grant C,Bayne C, Ureterocele Causing Bladder Outlet Obstruction. The Journal of pediatrics. 2018 Jul; [PubMed PMID: 29685621]|
|||Heyns CF, Urinary tract infection associated with conditions causing urinary tract obstruction and stasis, excluding urolithiasis and neuropathic bladder. World journal of urology. 2012 Feb; [PubMed PMID: 21720861]|
|||Gupta P,Sundaram V,Abraham G,Shantha GP,Mathew M, Obstructive uropathy from Ascaris lumbricoides. Kidney international. 2009 Jun; [PubMed PMID: 19444277]|
|||Gyang AN,Gomez NA,Lamvu GM, Endometriosis of the bladder as a cause of obstructive uropathy. JSLS : Journal of the Society of Laparoendoscopic Surgeons. 2014 Apr-Jun; [PubMed PMID: 24960507]|
|||Ganguli A,Chalokia RS,Kaur BJ, Obstructive Uropathy as an Initial Presentation of Primary Myelofibrosis: Case Report and Review of Literature. Indian journal of hematology [PubMed PMID: 27408371]|
|||McLean RH,Gearhart JP,Jeffs R, Neonatal obstructive uropathy. Pediatric nephrology (Berlin, Germany). 1988 Jan; [PubMed PMID: 3153001]|
|||El Imam M,Omran M,Nugud F,Elsabiq M,Saad K,Taha O, Obstructive uropathy in Sudanese patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2006 Sep; [PubMed PMID: 16970266]|
|||McNicholas T,Kirby R, Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS). BMJ clinical evidence. 2011 Aug 26; [PubMed PMID: 21871136]|
|||Matsusaka T,Miyazaki Y,Ichikawa I, The renin angiotensin system and kidney development. Annual review of physiology. 2002; [PubMed PMID: 11826279]|
|||Seseke F,Thelen P,Hemmerlein B,Kliese D,Zöller G,Ringert RH, Histologic and molecular evidence of obstructive uropathy in rats with hereditary congenital hydronephrosis. Urological research. 2000 Apr; [PubMed PMID: 10850632]|
|||Elder JS,Stansbrey R,Dahms BB,Selzman AA, Renal histological changes secondary to ureteropelvic junction obstruction. The Journal of urology. 1995 Aug; [PubMed PMID: 7609162]|
|||Steinhardt GF,Ramon G,Salinas-Madrigal L, Glomerulosclerosis in obstructive uropathy. The Journal of urology. 1988 Nov; [PubMed PMID: 3184311]|
|||Manjunath AS,Hofer MD, Urologic Emergencies. The Medical clinics of North America. 2018 Mar; [PubMed PMID: 29406065]|
|||Willette PA,Coffield S, Current trends in the management of difficult urinary catheterizations. The western journal of emergency medicine. 2012 Dec; [PubMed PMID: 23359117]|
|||Villanueva C,Hemstreet GP 3rd, Difficult male urethral catheterization: a review of different approaches. International braz j urol : official journal of the Brazilian Society of Urology. 2008 Jul-Aug; [PubMed PMID: 18778491]|
|||Chiou RK,Aggarwal H,Chen W, Glidewire-assisted Foley catheter placement: a simple and safe technique for difficult male catheterization. Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2009 Jun; [PubMed PMID: 19543460]|
|||Kenny AG,Pellerin O,Amouyal G,Desgranchamps F,Méria P,De Gouvello A,Dariane C,Déan C,Pereira H,Thiounn N,Sapoval M, Prostate Artery Embolization in Patients With Acute Urinary Retention. The American journal of medicine. 2019 Nov; [PubMed PMID: 31103644]|
|||Dunn CJ,Matheson A,Faulds DM, Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms. Drugs [PubMed PMID: 11950378]|
|||Narayan P,Tunuguntla HS, Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia. Reviews in urology. 2005; [PubMed PMID: 16986054]|
|||Lowe FC, Summary of clinical experiences with tamsulosin for the treatment of benign prostatic hyperplasia. Reviews in urology. 2005; [PubMed PMID: 16986050]|
|||Eri LM,Tveter KJ, Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH). Prostate cancer and prostatic diseases. 2001; [PubMed PMID: 12497037]|
|||Eri LM,Tveter KJ, A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia. The Journal of urology. 1993 Jul; [PubMed PMID: 7685428]|
|||Strutt KL,Blackledge GR,Kennealey GT, Re: A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia. The Journal of urology. 1994 May; [PubMed PMID: 7512665]|
|||Tacklind J,Fink HA,Macdonald R,Rutks I,Wilt TJ, Finasteride for benign prostatic hyperplasia. The Cochrane database of systematic reviews. 2010 Oct 6; [PubMed PMID: 20927745]|
|||Dougherty JM,Aeddula NR, Male Urinary Retention 2020 Jan; [PubMed PMID: 30860734]|
|||Roth KS,Koo HP,Spottswood SE,Chan JC, Obstructive uropathy: an important cause of chronic renal failure in children. Clinical pediatrics. 2002 Jun; [PubMed PMID: 12086196]|
|||Arthur RJ,Irving HC,Thomas DF,Watters JK, Bilateral fetal uropathy: what is the outlook? BMJ (Clinical research ed.). 1989 May 27; [PubMed PMID: 2502276]|
|||Stein R,Dogan HS,Hoebeke P,Kočvara R,Nijman RJ,Radmayr C,Tekgül S, Urinary tract infections in children: EAU/ESPU guidelines. European urology. 2015 Mar; [PubMed PMID: 25477258]|
|||Etafy MH,Saleh FH,Ortiz-Vanderdys C,Hamada A,Refaat AM,Aal MA,Deif H,Gawish M,Abdellatif AH,Gadalla K, Rapid versus gradual bladder decompression in acute urinary retention. Urology annals. 2017 Oct-Dec; [PubMed PMID: 29118535]|
|||Leslie SW,Sajjad H,Sharma S, Postobstructive Diuresis 2020 Jan; [PubMed PMID: 29083564]|